A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype

ABSTRACT: We previously reported CHFR methylation in a subset of colorectal cancer (CRC; ∼30%) with high concordance with microsatellite instability (MSI). We also showed that CHFR methylation predicted for sensitivity to docetaxel, whereas the MSI‐high phenotypes were sensitive to gemcitabine. We h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Sci
Main Authors: Baretti, Marina, Karunasena, Enusha, Zahurak, Marianna, Walker, Rosalind, Zhao, Yang, Pisanic, Thomas R., Wang, Tza‐Huei, Greten, Tim F., Duffy, Austin G., Gootjes, Elske, Meijer, Gerrit, Verheul, Henk M.W., Ahuja, Nita, Herman, James G., Azad, Nilofer S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8212722/
https://ncbi.nlm.nih.gov/pubmed/33811727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12960
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados